GSK will hold a 68 percent stake and Pfizer the remaining 32 percent of the new joint venture, which will be the world’s largest over-the-counter medicines business. The move will represent a breakup of GSK, which currently generates around a quarter of its revenue from such consumer products, according to The Wall Street Journal.
from Kaiser Health News https://ift.tt/2ECRbsI
December 19, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
IUDs After Birth: These Placement Options Can Lower Expulsion RisksHaving the device implanted right after delivery, or waiting four weeks, decreases a mother's chances of expelling the long-acting device, according to a new analysis. The researchers also examined the success rate following … Read More
Severe Viral Outbreak At A New Jersey Pediatric Center Leaves 6 Children Dead, 12 Others InfectedThe New Jersey Department of Health said it is conducting an investigation at the center, which has been cited in the past for health code violations and had a two-out-of-five star rating on health inspections from CMS. from… Read More
Juul’s Lobbying Spending Skyrockets 400 Percent Amid Government Crack Down On E-CigarettesJuul is facing increasing oversight from the FDA, which has made teens' use of e-cigarettes a top priority in recent months. Meanwhile, a study finds that a device that heats tobacco products -- which is being touted as safer… Read More
Citing Safety Of Roundup Weedkiller, Monsanto Commits To Long Legal Fight Against LawsuitsAfter a judge rejected the company's request Monday to reverse a lawsuit alleging the herbicide causes cancer, the pharmaceutical giant announced it will appeal and cited its experience in fighting mass lawsuits. from Kaiser… Read More
Medical Crowdfunding Culture Is Booming, But It’s Also Opening Door To False Hope And ScamsScientists are concerned that the crowdfunding economy is normalizing unproven and risky treatments that are designed to take advantage of patients in desperate need to cures. from Kaiser Health News https://ift.tt/2ApLkUo … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment